In the course of our screening program for new antibiotics, we found that a strain of Streptomyces sp.
MJ635-86F5 produced a new antibiotic, cremimycin (1, Fig, 1 ). Cremimycin showed broad antimicrobial activities against Gram-positive bacteria including MRSA.
In this paper, we describe the identification of the producing organism together with the isolation, fermentation, physico-chemical properties, structure elucidation and biological activities of cremimycin. 
Materials and Methods

General
Fermentation
A slant culture of the cremimycin-producing organism was inoculated into a 500-ml baffled Erlenmeyer flask containing 110ml of a seed medium consisting of galactose 2%, dextrin 2%, Bacto-soytone (Difco) 1.0%, corn steep liquor (Iwaki Co.) 0.5%, glycerol 1.0%, (NH4)2SO4 0.2% and CaCO3 0.2% in deionized water (pH 7.4 before sterilization). The culture was incubated seed culture (330ml) of the strain was transferred into a 30-liter jar fermentor containing 15 liters of a producing medium which was consisting of glucose 5%, soy bean meal 1%, polypepton 0.4%, yeast extract 0.1%, meat extract 0.4%, NaCl0.25% and CaCO3 0.5% in deionized water (pH 7.4). The fermentation was carried out at The antibiotic was monitored by the antibacterial activity against Staphylococcus aureus Smith and HPLC analysis during the purification process. A typical time course for production of cremimycin in the 30-liter jar fermenter was shown in Fig. 2 . The production of cremimycin in the broth started after 4 days of cultivation and reached a maximum (ca. 14mg/liter) after 8 days fermentation. The content of cremimycin in the mycelium reached maximum (ca. 120mg/liter) after 9 days or more fermentation.
The antibiotic in the mycelial cake was extracted with CHCl3-MeOH (1:1, 4 liter) and filtered. The extract was concentrated in vacuo to yield a brown oily material.
The oily material was extracted with a mixture of hexane- McOH (1:1, 2 liters) . The lower layer was collected and concentrated in vacuo to dryness yielding a brown material. The material containing cremimycin was dissolved in a mixed solvent of CHCl3-MeOH (4:1, 500ml) and washed with alkaline water (0.01N NaOH), acidic water (0.01N HCl), and deionized water successively. The organic layer was collected and concentrated Table 4 .
Cremimycin (1) contained five partial structures (a, b, c, d and e) from analyses of the 1H-1H COSY and HMQC spectra as shown in Fig. 3 . The presence of 19-membered macrocyclic lactam was revealed by con- Table 3 . Physico-chemical properties of cremimycin. Table 4 . 13C and 1H NMR data of cremimycin in DMSO-d6. is summarized in Fig. 3 .
Geometry for the three olefins at C-2, -4 and -6 in the 19-membered lactam moiety were revealed to be 2E, 4E, 6Z by their spin coupling constants (J2 , 3=15.0 and J4, 5=15.0Hz) and observing of NOE between 6-CH3 and 7-H, and 6-CH3 and 4-H in NOESY spectrum of 1. The sugar moiety was considered to be cymarose by its NMR data. The configuration of the anomeric center (J1' 2'eq=2.0 and J1' 2'ax=10.0Hz, J1',C-1'=162.1Hz) and observing of NOEs between 1'-H and 5'-H, and 1'-H and 3'-OCH3 in the NOESY spectrum. From the all above described results, the structure of cremimycin was determined as shown in Fig. 1 . Detailed stereochemical studies of cremimycin are now in progress.
Biological Activity
The antimicrobial activities of cremimycin are shown in Table. 5. Cremimycin exhibited broad and strong antibacterial activity against Gram-positive bacteria and no activities against Gram-negative bacteria, yeast and fungi including Pyricularia orizae. Cremimycin exhibited weak cytotoxicity against murine tumor cell lines in vitro.
The results are summarized in Table 6 . The acute toxicity of cremimycin was tested by intraperitoneal administrations into mice. 
